BIPH:OTO-Biophan Techs Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC Pink

Last Closing

USD 19.33

Change

+0.38 (+2.01)%

Market Cap

USD 0.19M

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Biophan Technologies Inc develops and markets cutting-edge technologies for the medical device industry. It develops biomedical devices that improve the delivery of healthcare.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-0.14 (-0.06%)

USD 67.69B
ALC Alcon AG

+0.12 (+0.12%)

USD 48.58B
RMD ResMed Inc

+2.84 (+1.14%)

USD 35.98B
BAX Baxter International Inc

+0.54 (+1.36%)

USD 20.26B
AVTR Avantor Inc

+0.32 (+1.19%)

USD 18.27B
TFX Teleflex Incorporated

N/A

USD 11.63B
ATR AptarGroup Inc

+0.71 (+0.47%)

USD 10.16B
STVN Stevanato Group SpA

N/A

USD 5.62B
BLCO Bausch + Lomb Corp

+2.25 (+14.47%)

USD 5.51B
WRBY Warby Parker Inc

+0.35 (+2.39%)

USD 1.57B

ETFs Containing BIPH

DXIF:CA Dynamic Active Internatio.. 6.37 % 0.00 %

+0.15 (+0.30%)

CAD 4.70M
C40:PA Amundi Index Solutions - .. 5.22 % 0.00 %

-0.16 (0.30%)

USD 0.99B
E40:PA BNP Paribas Easy CAC 40®.. 5.21 % 0.00 %

-0.02 (0.30%)

USD 0.21B
XEYX:XETRA BNP Paribas Easy CAC 40®.. 5.21 % 0.00 %

-0.02 (0.30%)

USD 0.32B
C40:SW Amundi Index Solutions - .. 5.14 % 0.00 %

N/A

N/A
C4DE:SW Amundi Index Solutions - .. 5.14 % 0.00 %

N/A

N/A
GC40:XETRA Amundi Index Solutions - .. 5.01 % 0.00 %

-0.16 (0.30%)

USD 0.91B
C4D:PA Amundi Index Solutions - .. 5.01 % 0.00 %

-0.15 (0.30%)

USD 0.16B
EXH4:XETRA iShares STOXX Europe 600 .. 4.97 % 0.00 %

-0.34 (0.30%)

USD 0.16B
ASWC:XETRA HANetf ICAV - Future of D.. 4.75 % 0.00 %

-0.03 (0.30%)

USD 0.47B
DX2G:XETRA Xtrackers - CAC 40 UCITS .. 4.26 % 0.00 %

-0.16 (0.30%)

USD 0.12B
CAC:PA Amundi CAC 40 UCITS ETF D.. 4.10 % 0.00 %

-0.17 (0.30%)

USD 3.28B
CACC:PA Lyxor CAC 40 (DR) UCITS E.. 4.10 % 0.00 %

-0.08 (0.30%)

USD 0.50B
STQ:PA SPDR® MSCI Europe Indust.. 4.07 % 0.00 %

-1.10 (0.30%)

USD 0.34B
SPYQ:XETRA SPDR® MSCI Europe Indust.. 4.07 % 0.00 %

-0.85 (0.30%)

USD 0.31B
STQX:SW SPDR® MSCI Europe Indust.. 4.07 % 0.00 %

-0.75 (0.30%)

USD 0.34B
ESIN:LSE iShares MSCI Europe Indus.. 3.98 % 0.00 %

-0.02 (0.30%)

USD 0.28B
ESIN:F Ishares VI PLC - Ishares .. 3.92 % 0.00 %

N/A

USD 0.21B
ESIN:XETRA Ishares VI PLC - Ishares .. 3.92 % 0.00 %

N/A

USD 0.16B
IS3U:XETRA iShares MSCI France UCITS 3.80 % 0.00 %

-0.12 (0.30%)

USD 0.11B
ISFR:LSE iShares MSCI France UCITS 3.77 % 0.00 %

-16.50 (0.30%)

USD 0.12B
IQQG:XETRA iShares EURO Total Market.. 3.32 % 0.00 %

-0.44 (0.30%)

USD 0.29B
GWT:PA Amundi MSCI Europe Growth.. 2.70 % 0.00 %

-0.82 (0.30%)

USD 0.11B
LGWT:XETRA Amundi MSCI Europe Growth.. 2.70 % 0.00 %

-0.94 (0.30%)

USD 0.20B
CGGO Capital Group Global Grow.. 2.70 % 0.00 %

+0.09 (+0.30%)

USD 4.10B
JIG JPMorgan International Gr.. 2.53 % 0.00 %

+0.20 (+0.30%)

USD 0.10B
CEMR:F iShares Edge MSCI Europe .. 2.32 % 0.00 %

-0.03 (0.30%)

USD 0.27B
CEMR:XETRA iShares Edge MSCI Europe .. 2.32 % 0.00 %

-0.03 (0.30%)

USD 0.33B
IEMO:SW iShares Edge MSCI Europe .. 2.32 % 0.00 %

N/A

USD 0.28B
CGGE Capital Group Global Equi.. 1.85 % 0.00 %

+0.08 (+0.30%)

N/A
SPVM Invesco S&P 500 Value wit.. 1.45 % 0.39 %

+0.57 (+0.30%)

USD 0.09B
VAMO 1.24 % 0.64 %

N/A

N/A
LOWV:LSE SPDR® S&P 500 Low Volati.. 1.24 % 0.00 %

+0.35 (+0.30%)

N/A
XRLV Invesco S&P 500® ex-Rate.. 1.21 % 0.25 %

+0.41 (+0.30%)

N/A
SPLV Invesco S&P 500® Low Vol.. 1.20 % 0.25 %

+0.53 (+0.30%)

USD 7.42B
EWQ iShares MSCI France ETF 0.00 % 0.47 %

+0.35 (+0.30%)

N/A
NDUS:LSE SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

-1.25 (0.30%)

N/A
EXH4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
GC40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
IQQG:F iShares Public Limited Co.. 0.00 % 0.00 %

-0.34 (0.30%)

N/A
IS3U:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.09 (+0.30%)

N/A
LGWT:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

-0.14 (0.30%)

N/A
SPYQ:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.15 (0.30%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.20% 63% D 78% C+
Dividend Return 3.72% 89% A- 72% C
Total Return 18.92% 68% D+ 80% B-
Trailing 12 Months  
Capital Gain 17.67% 68% D+ 69% C-
Dividend Return 3.80% 89% A- 55% F
Total Return 21.48% 74% C 70% C-
Trailing 5 Years  
Capital Gain N/A 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 73,601.81% 100% F 100% F
Dividend Return 73,604.22% 100% F 100% F
Total Return 2.40% 89% A- 51% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 5% F N/A F
Risk Adjusted Return 31.72% 74% C 51% F
Market Capitalization 0.19M 7% C- N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative earnings

The company had negative total earnings in the most recent four quarters.